Literature DB >> 32284552

Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity.

Dylan J Richards1,2, Yang Li1, Charles M Kerr3, Jenny Yao1,4, Gyda C Beeson5, Robert C Coyle1, Xun Chen1, Jia Jia1, Brooke Damon1, Robert Wilson6, E Starr Hazard7, Gary Hardiman7,8,9, Donald R Menick10,11, Craig C Beeson5, Hai Yao1, Tong Ye12, Ying Mei13,14.   

Abstract

Environmental factors are the largest contributors to cardiovascular disease. Here we show that cardiac organoids that incorporate an oxygen-diffusion gradient and that are stimulated with the neurotransmitter noradrenaline model the structure of the human heart after myocardial infarction (by mimicking the infarcted, border and remote zones), and recapitulate hallmarks of myocardial infarction (in particular, pathological metabolic shifts, fibrosis and calcium handling) at the transcriptomic, structural and functional levels. We also show that the organoids can model hypoxia-enhanced doxorubicin cardiotoxicity. Human organoids that model diseases with non-genetic pathological factors could help with drug screening and development.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32284552      PMCID: PMC7422941          DOI: 10.1038/s41551-020-0539-4

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   25.671


  91 in total

Review 1.  Intestinal organoids and personalized medicine in cystic fibrosis: a successful patient-oriented research collaboration.

Authors:  Jacquelien Noordhoek; Vincent Gulmans; Kors van der Ent; Jeffrey M Beekman
Journal:  Curr Opin Pulm Med       Date:  2016-11       Impact factor: 3.155

Review 2.  CRISPR/Cas 9 genome editing and its applications in organoids.

Authors:  Else Driehuis; Hans Clevers
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-01-26       Impact factor: 4.052

Review 3.  iPS cells: a game changer for future medicine.

Authors:  Haruhisa Inoue; Naoki Nagata; Hiromi Kurokawa; Shinya Yamanaka
Journal:  EMBO J       Date:  2014-02-05       Impact factor: 11.598

Review 4.  Organoids as an in vitro model of human development and disease.

Authors:  Aliya Fatehullah; Si Hui Tan; Nick Barker
Journal:  Nat Cell Biol       Date:  2016-03       Impact factor: 28.824

Review 5.  Disease modelling using human iPSCs.

Authors:  Stormy J Chamberlain
Journal:  Hum Mol Genet       Date:  2016-08-04       Impact factor: 6.150

Review 6.  The use of brain organoids to investigate neural development and disease.

Authors:  Elizabeth Di Lullo; Arnold R Kriegstein
Journal:  Nat Rev Neurosci       Date:  2017-09-07       Impact factor: 34.870

Review 7.  Organogenesis in a dish: modeling development and disease using organoid technologies.

Authors:  Madeline A Lancaster; Juergen A Knoblich
Journal:  Science       Date:  2014-07-17       Impact factor: 47.728

Review 8.  Concise Review: Organoids Are a Powerful Tool for the Study of Liver Disease and Personalized Treatment Design in Humans and Animals.

Authors:  Sathidpak Nantasanti; Alain de Bruin; Jan Rothuizen; Louis C Penning; Baukje A Schotanus
Journal:  Stem Cells Transl Med       Date:  2016-01-21       Impact factor: 6.940

Review 9.  Organoids in cancer research.

Authors:  Jarno Drost; Hans Clevers
Journal:  Nat Rev Cancer       Date:  2018-07       Impact factor: 60.716

Review 10.  Organoid technologies meet genome engineering.

Authors:  Jing Nie; Eri Hashino
Journal:  EMBO Rep       Date:  2017-02-15       Impact factor: 8.807

View more
  72 in total

1.  Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells.

Authors:  Giulia Campostrini; Viviana Meraviglia; Elisa Giacomelli; Ruben W J van Helden; Loukia Yiangou; Richard P Davis; Milena Bellin; Valeria V Orlova; Christine L Mummery
Journal:  Nat Protoc       Date:  2021-03-26       Impact factor: 13.491

Review 2.  Cardiac Organoids: A 3D Technology for Modeling Heart Development and Disease.

Authors:  Liyuan Zhu; Kui Liu; Qi Feng; Yingnan Liao
Journal:  Stem Cell Rev Rep       Date:  2022-05-08       Impact factor: 5.739

Review 3.  Cardiomyocyte Maturation-the Road is not Obstructed.

Authors:  Yaning Wang; Miao Yu; Kaili Hao; Wei Lei; Mingliang Tang; Shijun Hu
Journal:  Stem Cell Rev Rep       Date:  2022-07-05       Impact factor: 5.739

Review 4.  Recent advances in three-dimensional microelectrode array technologies for in vitro and in vivo cardiac and neuronal interfaces.

Authors:  Jong Seob Choi; Heon Joon Lee; Swaminathan Rajaraman; Deok-Ho Kim
Journal:  Biosens Bioelectron       Date:  2020-10-09       Impact factor: 10.618

Review 5.  Reconstructing the heart using iPSCs: Engineering strategies and applications.

Authors:  Sangkyun Cho; Chelsea Lee; Mark A Skylar-Scott; Sarah C Heilshorn; Joseph C Wu
Journal:  J Mol Cell Cardiol       Date:  2021-04-22       Impact factor: 5.000

Review 6.  Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production.

Authors:  Dilip Thomas; Nathan J Cunningham; Sushma Shenoy; Joseph C Wu
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

Review 7.  Cardiac organoid - a promising perspective of preclinical model.

Authors:  Dandan Zhao; Wei Lei; Shijun Hu
Journal:  Stem Cell Res Ther       Date:  2021-05-06       Impact factor: 6.832

Review 8.  Advances in development and application of human organoids.

Authors:  Abhijith Shankaran; Keshava Prasad; Sima Chaudhari; Angela Brand; Kapaettu Satyamoorthy
Journal:  3 Biotech       Date:  2021-05-08       Impact factor: 2.406

9.  A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues.

Authors:  Celinda M Kofron; Tae Yun Kim; Bum-Rak Choi; Kareen L K Coulombe; Fabiola Munarin; Arvin H Soepriatna; Rajeev J Kant; Ulrike Mende
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

10.  Promotion of Differentiating Bone Marrow Mesenchymal Stromal Cells (BMSCs) into Cardiomyocytes via HCN2 and HCN4 Cotransfection.

Authors:  Xue Luo; Hongxiao Li; Xiaolin Sun; Qisheng Zuo; Bichun Li; Ye Zhu; Wei Wei; Xiang Gu
Journal:  Biomed Res Int       Date:  2021-05-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.